Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Persistent idiopathic facial pain treated with botulinum toxin and pulsed radiofrequency of infraorbital nerve - a case report

  • Vadhanan, Prasanna (Department of Anaesthesiology, Vinayaka Missions Medical College, Vinayaka Missions Research Foundation)
  • Received : 2021.11.11
  • Accepted : 2022.01.04
  • Published : 2022.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Persistent idiopathic facial pain is a rare and difficult condition to treat. Several pharmacological, nonpharmacological, and invasive treatment options have been used, with varying results. We report the case of a patient with intractable persistent idiopathic facial pain who responded favorably to a combination of botulinum toxin injections and pulsed radiofrequency treatment of the infraorbital nerve.

Keywords

Acknowledgement

The author declares no funding for this study.

References

  1. Gerwin R. Chronic facial pain: trigeminal neuralgia, persistent idiopathic facial pain, and myofascial pain syndrome-an evidence-based narrative review and etiological hypothesis. Int J Environ Res Public Health 2020; 17: 7012. https://doi.org/10.3390/ijerph17197012
  2. Gobel H. 13.12 Persistent idiopathic facial pain (PIFP). ICHD-3. Available from https://ichd-3.org/13-painful-cranial-neuropathies-and-other-facial-pains/13-12-central-neuropathic-pain/.
  3. Sukenaga N, Matsuki Y, Maeda L, Nagai T, Hashimoto K, Takao Y et al. Neuropathic characteristics in patients with persistent idiopathic facial pain. J Pain Res 2019; 12: 2801-5. https://doi.org/10.2147/JPR.S218332
  4. Koopman JS, Dieleman JP, Huygen FJ. Incidence of facial pain in the general population. Pain 2009; 147: 122-7. https://doi.org/10.1016/j.pain.2009.08.023
  5. Maarbjerg S, Wolfram F, Heinskou TB, Rochat P, Gozalov A, Brennum J et al. Persistent idiopathic facial pain - a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRI. Cephalalgia 2017; 37: 1231-40. https://doi.org/10.1177/0333102416675618
  6. Benoliel R, Gaul C. Persistent idiopathic facial pain. Cephalalgia 2017; 37: 680-91. https://doi.org/10.1177/0333102417706349
  7. International classification of orofacial pain, 1st edition (ICOP). Cephalalgia 2020; 40: 129-221. https://doi.org/10.1177/0333102419893823
  8. Rahimpour S, Lad SP. Surgical options for atypical facial pain syndromes. Neurosurg Clin N Am 2016; 27: 365-70. https://doi.org/10.1016/j.nec.2016.02.010
  9. Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, et al. Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study. J Headache Pain 2019; 20: 10. https://doi.org/10.1186/s10194-018-0952-1
  10. Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins 2017; 9: 260. https://doi.org/10.3390/toxins9090260
  11. Rubis A, Juodzbalys G. The use of botulinum toxin A in the management of trigeminal neuralgia: a systematic literature review. J Oral Maxillofac Res 2020 Jun 30; 11: e2.
  12. Kim SY, Kim YK, Yun PY, Bae JH. Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study. Maxillofac Plast Reconstr Surg 2018; 40: 21. https://doi.org/10.1186/s40902-018-0159-z
  13. Garcia-Saez R, Gutierrez-Viedma A, Gonzalez-Garcia N, Gomez-Mayordomo V, Porta-Etessam J, Cuadrado ML. OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients. J Pain Res 2018; 11: 1583-8. https://doi.org/10.2147/JPR.S169701
  14. Huang X, Ma Y, Wang W, Guo Y, Xu B, Ma K. Efficacy and safety of pulsed radiofrequency modulation of thoracic dorsal root ganglion or intercostal nerve on postherpetic neuralgia in aged patients: a retrospective study. BMC Neurol 2021; 21: 233. https://doi.org/10.1186/s12883-021-02286-6
  15. Orhurhu V, Khan F, Quispe RC, Huang L, Urits I, Jones M, et al. Use of radiofrequency ablation for the management of facial pain: a systematic review. Pain Physician 2020; 23: 559-80.